Comparative ex vivo inhibitory effects of (E)-2-(3,4-dimethoxyphenyl)-3-fluoroallylamine (MDL 72145) on amine oxidase activities in the rat.
Lyles
G A
GA
Department of Pharmacology and Clinical Pharmacology University of Dundee Ninewells Hospital and Medical School, U.K.
Marshall
C M
CM
Flucker
C J
CJ
D000499:Allylamine / Q000031:analogs & derivatives / Q000494:pharmacology*; D006631:Amine Oxidase (Copper-Containing); D000588:Amines / Q000494:pharmacology*; D000818:Animals; D008297:Male; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology*; D009928:Organ Specificity; D000587:Oxidoreductases Acting on CH-NH Group Donors / Q000037:antagonists & inhibitors*; D051381:Rats; D011919:Rats, Inbred Strains
D000588:Amines; D008996:Monoamine Oxidase Inhibitors; D000499:Allylamine; C040051:2-(3,4-dimethoxyphenyl)-3-fluoroallylamine; D006631:Amine Oxidase (Copper-Containing); D000587:Oxidoreductases Acting on CH-NH Group Donors